The U.S. Senate on Sunday passed historic legislation to let Medicare negotiate the prices of a small number of costly medicines and require drug manufacturers to pay Medicare rebates when prices paid by Medicare rise faster than inflation.
Language in the bill makes it clear that 340B covered entities will be able to access the lower of the 340B price or the negotiated Medicare price, 340B hospital representatives have said.
The U.S. Senate on Sunday passed historic legislation to let Medicare to negotiate the prices of a small number of costly medicines and require drug manufacturers to pay Medicare rebates when prices paid by Medicare rise faster than inflation.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
